| Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236 S Fujita, A Plianchaisuk, S Deguchi, H Ito, N Nao, L Wang, H Nasser, ... EBioMedicine 104, 2024 | | 2024 |
| Intragenic silencer regulates human retrovirus latency by recruiting RUNX1 Y Satou, K Sugata, A Rahman, K Niimura, K Monde, T Ueno, S Rajib, ... | | 2024 |
| Further Characterization of the Antiviral Transmembrane Protein MARCH8 T Tada, Y Zhang, D Kong, M Tanaka, W Yao, M Kameoka, T Ueno, ... Cells 13 (8), 698, 2024 | | 2024 |
| Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV I Ngare, TS Tan, M Toyoda, T Kuwata, S Takahama, E Nakashima, ... Viruses 16 (4), 555, 2024 | | 2024 |
| Neutralizing immunity against coronaviruses in Tanzanian health care workers G Barabona, I Ngare, D Kamori, L Nkinda, Y Kosugi, A Mawazo, R Ekwabi, ... Scientific reports 14 (1), 5508, 2024 | | 2024 |
| Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2 Y Maeda, M Toyoda, T Kuwata, H Terasawa, U Tokugawa, K Monde, ... International Journal of Molecular Sciences 25 (2), 1353, 2024 | | 2024 |
| Characteristics of the SARS-CoV-2 omicron HK. 3 variant harbouring the FLip substitution Y Kosugi, A Plianchaisuk, O Putri, K Uriu, Y Kaku, AA Hinay, L Chen, ... The Lancet Microbe, 2024 | 7 | 2024 |
| Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving … Y Tomita, S Sakata, K Imamura, S Iyama, T Jodai, K Saruwatari, ... Cancers 16 (1), 47, 2023 | 2 | 2023 |
| Differential Ability of S Protein of SARS-CoV-2 Variants to Downregulate ACE2 Y Maeda, M Toyoda, T Kuwata, H Terasawa, U Tokugawa, K Monde, ... Preprints, 2023 | | 2023 |
| Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity E Nkuwi, GP Judicate, TS Tan, G Barabona, M Toyoda, B Sunguya, ... Journal of Virology 97 (10), e00823-23, 2023 | 2 | 2023 |
| Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2 S Fujita, Y Kosugi, I Kimura, K Tokunaga, J Ito, K Sato, K Matsuno, N Nao, ... Journal of Virology, 2023 | 1 | 2023 |
| Evaluation of Neutralizing Activity against Omicron Subvariants in BA. 5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated … M Toyoda, TS Tan, C Motozono, G Barabona, A Yonekawa, N Shimono, ... Microbiology spectrum 11 (4), e00660-23, 2023 | 2 | 2023 |
| Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV-infected adults initiating antiretroviral therapy in Urban Tanzania TM Mwakyandile, GA Shayo, PG Sasi, FM Mugusi, G Barabona, T Ueno, ... BMC Cardiovascular Disorders 23 (1), 309, 2023 | 2 | 2023 |
| Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance … D Kamori, G Barabona, J Rugemalila, W Maokola, SS Masoud, ... Journal of Antimicrobial Chemotherapy 78 (3), 779-787, 2023 | 12 | 2023 |
| HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania J Rugemalila, D Kamori, P Kunambi, M Mizinduko, A Sabasaba, ... Plos one 18 (2), e0281528, 2023 | 7 | 2023 |
| Characterization of a novel CD4 mimetic compound YIR-821 against HIV-1 clinical isolates K Matsumoto, T Kuwata, WD Tolbert, J Richard, S Ding, J Prévost, ... Journal of Virology 97 (1), e01638-22, 2023 | 2 | 2023 |
| The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA. 1 variant I Kimura, D Yamasoba, H Nasser, J Zahradnik, Y Kosugi, J Wu, K Nagata, ... Iscience 25 (12), 2022 | 24 | 2022 |
| Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19 H Ogura, J Gohda, X Lu, M Yamamoto, Y Takesue, A Son, S Doi, ... Nature communications 13 (1), 7063, 2022 | 7 | 2022 |
| Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay H Nasser, R Shimizu, J Ito, K Matsuno, N Nao, H Sawa, M Kishimoto, ... STAR protocols 3 (4), 101773, 2022 | 16 | 2022 |
| Erratum for Tan et al.,“Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike” TS Tan, M Toyoda, H Ode, G Barabona, H Hamana, M Kitamatsu, H Kishi, ... Journal of Virology 96 (23), e01737-22, 2022 | | 2022 |
